Fused pyrimidine derivatives and compositions thereof as CXCR3 receptor modulators, useful in prevention and treatment of inflammatory and immunoregulatory disorders and diseases
Details for Australian Patent Application No. 2005260620 (hide)
International Classifications
Event Publications
15 February 2007 PCT application entered the National Phase
PCT publication WO2006/004915 Priority application(s): WO2006/004915
4 October 2007 Amendment Made
The nature of the amendment is: Add co-inventor Liu, Jiwen
17 April 2008 Assignment before Grant
Amgen SF, LLC The application has been assigned to Amgen Inc.
2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005260629-Imidazolo-related compounds, compositions and methods for their use
2005260614-Combined electromagnetic and optical communication system
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser